反义和 RNAi 治疗市场(主要地区、市场参与者、规模和份额)- 2031 年预测

  • Report Code : TIPRE00023784
  • Category : Life Sciences
  • No. of Pages : 150
Buy Now

反义和 RNAi 治疗市场预计在 2024 年至 2031 年期间的复合年增长率为 7.50%,市场规模将从 2024 年的 XX 百万美元扩大到 2031 年的 XX 百万美元。

报告根据类型(RNA 干扰、反义 RNA)进行了分析。报告按给药途径(肺部给药、静脉注射、皮内注射、腹膜内注射、局部注射、其他)进行细分。报告还根据应用(传染病、心血管疾病、癌症、神经系统疾病等)提供分析。全球分析进一步细分为区域和主要国家。范围涵盖所有关键细分市场的全球、区域和国家层面的市场规模和预测。报告以美元为单位提供了上述分析和细分市场的价值。报告提供了主要市场参与者的市场状况的关键统计数据,并提供了市场趋势和机会。

报告目的

The Insight Partners 发布的《反义和 RNAi 治疗市场》报告旨在描述当前形势和未来增长、主要驱动因素、挑战和机遇。这将为各种业务利益相关者提供见解,例如:

  • 技术提供商/制造商:了解不断变化的市场动态并了解潜在的增长机会,从而能够做出明智的战略决策。
  • 投资者:对市场增长率、市场财务预测以及整个价值链中存在的机会进行全面的趋势分析。
  • 监管机构:监管市场政策和警察活动,旨在最大限度地减少滥用行为,维护投资者的信任和信心,维护市场的完整性和稳定性。

 

反义和 RNAi 治疗市场细分

 

类型

  • RNA干扰
  • 反义RNA

给药途径

  • 肺部给药
  • 静脉注射
  • 皮内注射
  • 腹腔内
  • 主题
  • 其他的

应用

  • 传染病
  • 心血管疾病
  • 癌症
  • 神经系统疾病
  • 其他的

地理

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

 

定制此报告以满足您的需求

您可以免费定制任何报告,包括本报告的部分内容、国家级分析、Excel 数据包,以及为初创企业和大学提供优惠和折扣

反义和 RNAi 治疗市场:战略洞察

Antisense and RNAi Therapeutics Market
  • 获取此报告的关键市场趋势。
    这个免费样品将包括数据分析,从市场趋势到估计和预测。

 

反义和 RNAi 治疗市场的增长动力

  • 疾病遗传发病率增加:遗传疾病(包括罕见疾病)发病率的增加是反义和 RNAi 治疗市场的主要推动力。疗法针对特定突变,为杜氏肌营养不良症和囊性纤维化等疾病提供个性化治疗选择;因此,基因沉默技术的需求不断增加。
  • RNA 技术的进步:RNA 技术的不断进步、改进的输送系统和增强的 RNA 分子稳定性有望推动反义和 RNAi 治疗市场的发展。精准度和功效的提高将使这些疗法在临床应用中更加可行和有效。
  • 基因疗法投资增加:基因疗法投资增加,推动反义和 RNAi 治疗市场蓬勃发展。制药公司投入大量资金开发 RNA 靶向药物,同时政府和私人投资者也资助他们的研究,为快速发展和新 RNA 疗法用于治疗疾病铺平了道路。

反义和 RNAi 治疗市场未来趋势

  • 个性化医疗方法:个性化 RNA 疗法是一种根据个人基因组成形成的新型治疗方法。这种治疗形式能够开发针对特定基因突变的治疗方法,从而提高疗效、减少副作用并改善患者治疗效果。因此,它塑造了基于 RNA 的治疗创新的未来,并建立了一种更精确的疾病治疗模式。
  • 创新 RNA 递送系统:未来基于 RNA 的疗法在于开发新型 RNA 递送技术,例如基于纳米粒子的载体、脂质纳米粒子和几种新兴的递送系统,以挑战 RNA 稳定性和基因沉默效率的局限性,这反过来将使市场关注实用性和可扩展性。
  • RNAi 联合疗法:RNAi 疗法与其他治疗方式(如免疫疗法或小分子)的联合使用趋势日益增长。这些疗法应能改善治疗效果,因为它们同时针对多个途径,因此有望提高疗效和/或扩大 RNA 疗法在肿瘤、心血管和遗传疾病治疗中的适应症和应用。

反义和 RNAi 治疗市场机会

  • 更加关注罕见病:随着 RNA 疗法有望治疗此类疾病,孤儿病和其他罕见病的关注度正在不断提高。目前,许多罕见遗传病尚无有效治疗方法,反义和 RNAi 方法是解决供需缺口并推动这些细分领域研发的一种新方法。采用此类创新方法的联合疗法或共同开发基因编辑可以帮助扩大治疗范围,并加速为复杂疾病带来新的干预措施。
  • 开发非处方 RNAi 疗法:开发非处方 RNAi 疗法是一个很好的商机,尤其是针对不需要临床治疗的皮肤病或慢性病。此类疗法将大大促进自我护理和个性化医疗的发展,自我护理正日益成为使用 RNAi 产品的一种可行模式——后者甚至已经完全脱离了医疗保健的范围,甚至低于医疗保健的范围。
  • 专注于癌症治疗:癌症是反义和 RNAi 治疗领域的一大机遇。针对肿瘤发生中涉及的特定致癌基因也可以实现个性化治疗,且副作用更少。随着精准肿瘤学的兴起,将 RNA 疗法扩展到此类癌症治疗中效果理想,这是一个极具吸引力的机会。

 

反义和 RNAi 治疗市场区域洞察

Insight Partners 的分析师已详尽解释了预测期内影响反义和 RNAi 治疗市场的区域趋势和因素。本节还讨论了北美、欧洲、亚太地区、中东和非洲以及南美和中美洲的反义和 RNAi 治疗市场细分和地理位置。

Antisense and RNAi Therapeutics Market
  • 获取反义和 RNAi 治疗市场的区域特定数据

反义和 RNAi 治疗市场报告范围

报告属性细节
2024 年的市场规模XX 百万美元
2031 年市场规模XX 百万美元
全球复合年增长率(2025 - 2031)7.50%
史料2021-2023
预测期2025-2031
涵盖的领域按类型
  • RNA干扰
  • 反义RNA
按给药途径
  • 肺部给药
  • 静脉注射
  • 皮内注射
  • 腹腔内
  • 主题
  • 其他的
按应用
  • 传染病
  • 心血管疾病
  • 癌症
  • 神经系统疾病
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  • Alnylam 制药公司
  • Benitec Biopharma 有限公司
  • 夸克制药公司
  • 伊奥尼斯制药公司
  • 安斯泰来制药公司
  • 玛丽娜生物科学公司
  • 赛诺菲
  • Dicerna 制药公司
  • Tekmira 制药公司

 

反义和 RNAi 治疗市场参与者密度:了解其对业务动态的影响

反义和 RNAi 治疗市场正在快速增长,这得益于终端用户需求的不断增长,而这些需求又源于消费者偏好的不断变化、技术进步以及对产品优势的认识不断提高等因素。随着需求的增加,企业正在扩大其产品范围,进行创新以满足消费者的需求,并利用新兴趋势,从而进一步推动市场增长。

市场参与者密度是指在特定市场或行业内运营的企业或公司的分布情况。它表明在给定市场空间中,相对于其规模或总市场价值,有多少竞争对手(市场参与者)存在。

在反义和 RNAi 治疗市场运营的主要公司有:

  1. Alnylam 制药公司
  2. Benitec Biopharma 有限公司
  3. 夸克制药公司
  4. 伊奥尼斯制药公司
  5. 安斯泰来制药公司

免责声明上面列出的公司没有按照任何特定顺序排列。


Antisense and RNAi Therapeutics Market

 

  • 获取反义和 RNAi 治疗市场顶级关键参与者概述

 

 

主要卖点

 

  • 全面覆盖:该报告全面涵盖了反义和 RNAi 治疗市场的产品、服务、类型和最终用户的分析,提供了整体概况。
  • 专家分析:报告基于对行业专家和分析师的深入了解而编写。
  • 最新信息:该报告涵盖了最新信息和数据趋势,确保了其与业务的相关性。
  • 定制选项:此报告可以定制以满足特定客户要求并恰当地适应业务策略。

因此,反义和 RNAi 治疗市场研究报告有助于引领解读和了解行业情景和增长前景。尽管可能存在一些合理的担忧,但本报告的总体优势往往大于劣势。

  • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
  • PEST and SWOT Analysis
  • Market Size Value / Volume - Global, Regional, Country
  • Industry and Competitive Landscape
  • Excel Dataset
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which region dominated the antisense and RNAi therapeutics market in 2023?

North America region dominated the antisense and RNAi therapeutics market in 2023

Which region higesh CAGR the antisense and RNAi therapeutics market in 2023?

Asia Pacific region dominated the antisense and RNAi therapeutics market in 2023

Major trend in the market

Advancing trend in POC testing

Which are some of the major players operating in the market?

Abbott, biomeruix SA, Quest Diagnostics, Biomerica, Danaher corporation, Trinity biotech, BD, Bio-rad Laboratories

What are the driving factors impacting the antisense and RNAi therapeutics market ?

The major driving factors of antisense and RNAi therapeutics market are:

1. Increased cases of TB worldwide

2. Advances in Diagnostic Technologies

3. Igovernment initiatives and funding

What is the expected CAGR of the Antisense and RNAi Therapeutics Market ?

The Antisense and RNAi Therapeutics Market is estimated to witness a CAGR of 7.50% from 2023 to 2031

Trends and growth analysis reports related to Life Sciences : READ MORE..   
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

The List of Companies

1. Alnylam Pharmaceuticals
2. Benitec Biopharma Ltd.
3. Quark Pharmaceuticals
4. Ionis Pharmaceuticals
5. Astellas Pharma Inc
6. Marina Biosciences
7. Sanofi S
8. Dicerna Pharmaceuticals
9. Tekmira Pharmaceuticals
10. Merck

Buy Now  

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.